Global Bone Injection Guns (BIG) Market Size By Type (Delivery of Fluids, Delivery of Medications), By Application (Hospitals, Ambulatory Surgical Center), By Region, And Segment Forecasts, 2023 to 20...

The Global Bone Injection Guns (BIG) Market was valued at USD 312 million in 2023 and is expected to reach USD 552 million by 2031, growing at a CAGR of 7.4% during the forecast period from 2023 to 2031. The market growth is primarily driven by the increasing demand for rapid intraosseous (IO) access in emergency medical services, the rising number of trauma cases and military applications, and the expanding need for reliable vascular access in critical care scenarios. Bone injection guns offer a fast, effective, and minimally invasive alternative to traditional intravenous access, especially when veins are inaccessible due to shock or trauma.

Drivers:

Rising Demand for Emergency and Military Medical Equipment:

The increasing prevalence of emergency medical situations, including accidents, cardiac arrests, and battlefield trauma, necessitates quick vascular access. Bone injection guns provide immediate access to the vascular system through the bone marrow, making them crucial for paramedics, military personnel, and emergency responders.

Advancement in Intraosseous Device Technology:

Technological improvements, such as spring-loaded mechanisms, compact designs, and pediatric compatibility, are boosting the adoption of BIGs. These advancements improve reliability, ease of use, and application across varied patient demographics.

Increasing Hospital Admissions and Chronic Disease Burden:

The global rise in chronic illnesses and the elderly population contributes to a higher number of hospitalizations requiring quick fluid resuscitation and medication delivery, supporting the adoption of BIGs in intensive care units.

Restraints:

High Cost and Limited Reusability:

Bone injection guns are often single-use devices, and their cost can be a barrier for wide-scale implementation, particularly in low-income or rural settings with limited healthcare budgets.

Lack of Awareness and Training Among Healthcare Providers:

Despite the advantages, adoption is hindered in some regions due to a lack of awareness or insufficient training on the usage of BIGs, which could impact patient outcomes if used incorrectly.

Opportunity:

Expanding Use in Pediatric and Disaster Medicine:

As BIG devices become increasingly refined for pediatric use, new opportunities are opening in child emergency care. Furthermore, their utility in disaster response and humanitarian missions presents substantial growth potential in untapped markets.

Integration in Ambulance and Pre-Hospital Care Systems:

The global emphasis on improving pre-hospital care infrastructure presents an opportunity for the integration of BIGs into standard EMS equipment kits, especially in countries developing their emergency medical response systems.

Market by System Type Insights:

The market is segmented into Manual Bone Injection Guns and Automatic Bone Injection Guns. The Automatic segment dominated in 2023 due to its ease of use, especially in high-pressure emergency settings. These devices reduce the margin for operator error and offer quicker intraosseous access, which is vital during the golden hour of trauma care.

Market by End-use Insights:

In 2023, the Emergency Medical Services (EMS) segment accounted for the largest share. EMS professionals increasingly rely on BIGs for their reliability in situations where venous access is challenging. The Military & Defense segment is expected to grow at the highest CAGR, driven by rising defense budgets and battlefield medical readiness programs globally.

Market by Regional Insights:

North America held the largest market share in 2023, supported by advanced healthcare infrastructure, high awareness levels, and the strong presence of EMS services. Asia-Pacific is anticipated to witness the fastest growth through 2031 due to growing investment in emergency healthcare systems, increasing trauma cases, and favorable government initiatives in countries like India and China.

Competitive Scenario:

Prominent players in the global Bone Injection Guns market include PerSys Medical, Teleflex Incorporated, Cook Medical, Biopsybell Srl, and SAM Medical. These companies focus on R&D, product innovation, and strategic partnerships to strengthen their foothold.

In 2023, PerSys Medical expanded its BIG product line to include pediatric models for EMS units globally.

In 2024, Teleflex launched a campaign to improve practitioner training across emerging markets.

Cook Medical reported increased investment in intraosseous access technology research in 2025, focusing on reusable device innovation.

Scope of Work – Global Bone Injection Guns (BIG) Market

Report Metric Details

Market Size (2023) USD 312 million

Projected Market Size (2031) USD 552 million

CAGR (2023-2031) 7.4%

Market Segments By System Type (Manual, Automatic);

By End-use (EMS, Hospitals, Military, Disaster Relief)

Growth Drivers Increasing trauma cases,

technological advancements,

adoption in military and EMS sectors

Opportunities Pediatric and disaster care expansion,

integration with EMS systems globally

Key Market Developments:

2023: PerSys Medical launched a new BIG device optimized for pediatric trauma care, expanding its reach in emergency medicine.

2024: Teleflex announced a global education initiative aimed at increasing BIG usage training among paramedics and field responders.

2025: Cook Medical invested in R&D focused on reusable bone injection systems, addressing the high cost barrier in emerging markets.

FAQs:

What is the current market size of the Global Bone Injection Guns (BIG) Market?

The market was valued at USD 312 million in 2023.

What is the major growth driver of the Global Bone Injection Guns (BIG) Market?

The primary driver is the growing demand for rapid vascular access in emergency and trauma care.

Which is the largest region during the forecast period in the Global Bone Injection Guns (BIG) Market?

North America holds the largest share due to its advanced EMS systems and high adoption rates.